Patent 9308213 was granted and assigned to infirst Healthcare on April, 2016 by the United States Patent and Trademark Office.
The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.